anonymous
Guest
anonymous
Guest
If you are not in a panic yet about your job and the future of the company maybe you don't have a firm grasp on the situation! Here are a few obvious facts:
- The geniuses who mismanaged the approval process for 5461 and who who really pissed off the FDA have paid no price and some have been promoted.
- The FRMs try to teach our customers how to navigate a broken and dysfunctional fulfillment system instead of Alkermes trying to fix the fulfillment system.
- The company lobbied the federal government for additional dollars to address the opiate epidemic, but didn't insist that the rules for using these dollars gave Vivitrol a fair shake. As a result the additional federal dollars to treat addiction mostly helped to expand the use of buprenorphine and our relative market share is worse than before.